This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 3 from Patent US 20070264275
General Information
DCTPep ID DCTPep01295
Peptide Name Sequence 3 from Patent US 20070264275
Sequence LPPDVQRV
Sequence Length 8
PubChem CID Not available
Origin Homo sapiens
Type Native peptide
Classification
ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C41H70N12O12
Absent amino acids ACEFGHIKMNSTWY
Theoretical pI 5.84
Acidic residues 1
Basic residues 1
Polar residues 0
Molecular weight (Average) 923.08
Molecular weight (Monoisotopic) 922.52
Common amino acids PV
Net charge 0
Instability index (II) 47.48
Aliphatic index 121.25
Grand average of hydropathicity (GRAVY) -0.312
Half Life
5.5 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2007/0264275 A1
Patent Title Peptides Derived from the Protein Mmp-4, and the Use Thereof in Antitumoral Immunotherapy.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: US, CA, EP, JP, FR, WO; Legal Status: Inactive; Application No: 56195104; Filed:Jun 24, 2004; Published: Nov 15, 2007; Earliest Priority: Jun 25, 2003; Granted: Dec 8, 2009
Other Published ID CA2529943A1 EP1635862A1 US7629439 WO2005000342A1
This work is licensed under a Creative Commons Attribution 4.0 International License.